From Directly-Observed Therapy (DOT) to Digital Adherence Technology (DAT) for TB Treatment
Not Applicable
- Conditions
- Tuberculosis
- Registration Number
- PACTR201808609844917
- Lead Sponsor
- niversity of California San Francisco
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 3060
Inclusion Criteria
Site-level Inclusion Criteria: 1. Diagnosed >10 PTB patients/month in 2017; 2. Not located within Kampala District; 3. Located within 225km of Kampala city; 4. PTB treatment success rate in 2016 of <80%
Patient-level Inclusion Criteria: 1. Initiating Category I treatment for active pulmonary TB at a study facility during the study period
Exclusion Criteria
Site-level Exclusion Criteria: 1. Do not agree to participate in the trial
Patient-level Exclusion Criteria: 1. Diagnosed with extra-pulmonary TB; 2. Diagnosed with or referred for evaluation of drug-resistant TB; 3. Does not own a mobile phone with SMS capabilities
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method